Roberto D. B.
- Country
- Spain
- Department
- Oncology
Research Overview
- Evaluation of Safety and Tolerability of CEB-01 PLGA Membrane in Patients with Recurrent or Locally Advanced Retroperitoneal Soft Tissue Sarcoma Post-Surgery
- Comparative Study of JPB898 and Nivolumab in Combination with Ipilimumab for Advanced Unresectable/Metastatic Melanoma
- Pharmacokinetics Study Comparing GME751 and US/EU-Approved Pembrolizumab in Stage II and III Melanoma Patients Requiring Adjuvant Therapy
Data & Insights
Has run more than one trial at 138 of 282 partner sites.
Specializations
Oncology - Skin Cancers
The investigator demonstrates significant involvement in research focused on advanced melanoma treatments and cutaneous squamous cell carcinoma. Their work encompasses both metastatic and unresectable cases, with particular attention to adjuvant therapy approaches.
- Advanced and Metastatic Melanoma
- High-Risk Cutaneous Squamous Cell Carcinoma
- Immunotherapy Combinations
Gastrointestinal and Hepatic Oncology
The investigator conducts research in the treatment of pancreatic adenocarcinoma, biliary tract cancer, and hepatocellular carcinoma, exploring innovative therapeutic approaches including combination treatments.
- Metastatic Pancreatic Cancer
- HER2-Positive Biliary Tract Cancer
- Advanced Hepatocellular Carcinoma
Musculoskeletal Oncology
The investigator specializes in treating various forms of sarcomas and bone-related cancers, including conventional chondrosarcoma and tenosynovial giant cell tumour.
- Soft Tissue and Bone Sarcomas
- Metastatic Leiomyosarcoma
- Chondrosarcoma Treatment
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.